1. Home
  2. SABS vs WKHS Comparison

SABS vs WKHS Comparison

Compare SABS & WKHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
  • WKHS
  • Stock Information
  • Founded
  • SABS 2014
  • WKHS 2007
  • Country
  • SABS United States
  • WKHS United States
  • Employees
  • SABS N/A
  • WKHS N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • WKHS Auto Manufacturing
  • Sector
  • SABS Health Care
  • WKHS Consumer Discretionary
  • Exchange
  • SABS Nasdaq
  • WKHS Nasdaq
  • Market Cap
  • SABS 15.8M
  • WKHS 17.4M
  • IPO Year
  • SABS N/A
  • WKHS N/A
  • Fundamental
  • Price
  • SABS $2.34
  • WKHS $1.11
  • Analyst Decision
  • SABS Strong Buy
  • WKHS Hold
  • Analyst Count
  • SABS 4
  • WKHS 2
  • Target Price
  • SABS $9.50
  • WKHS $8.68
  • AVG Volume (30 Days)
  • SABS 481.4K
  • WKHS 1.3M
  • Earning Date
  • SABS 11-05-2025
  • WKHS 11-18-2025
  • Dividend Yield
  • SABS N/A
  • WKHS N/A
  • EPS Growth
  • SABS N/A
  • WKHS N/A
  • EPS
  • SABS N/A
  • WKHS N/A
  • Revenue
  • SABS $114,698.00
  • WKHS $10,745,014.00
  • Revenue This Year
  • SABS N/A
  • WKHS $92.70
  • Revenue Next Year
  • SABS N/A
  • WKHS $34.00
  • P/E Ratio
  • SABS N/A
  • WKHS N/A
  • Revenue Growth
  • SABS N/A
  • WKHS 11.73
  • 52 Week Low
  • SABS $1.00
  • WKHS $0.81
  • 52 Week High
  • SABS $6.60
  • WKHS $24.25
  • Technical
  • Relative Strength Index (RSI)
  • SABS 55.11
  • WKHS 36.14
  • Support Level
  • SABS $1.85
  • WKHS $1.05
  • Resistance Level
  • SABS $2.49
  • WKHS $1.24
  • Average True Range (ATR)
  • SABS 0.21
  • WKHS 0.07
  • MACD
  • SABS 0.01
  • WKHS 0.01
  • Stochastic Oscillator
  • SABS 47.00
  • WKHS 19.95

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

Share on Social Networks: